The FDA is now considering whether to allow the creation of biofuels.
The new draft rules would allow for the use of biofuel, biofuel-derived products and biofuELVES (energy-extractable liquid products) as a treatment for conditions such as cancer, heart disease and obesity.
In a statement to Reuters, FDA Commissioner Scott Gottlieb said that the agency is “committed to moving toward a cleaner energy future by making it easier for Americans to use the most environmentally friendly sources of energy, as well as providing consumers with more choices to choose from when it comes to biofueling.”
“We know that Americans are interested in using this new approach to biofuel production and that it could potentially be a game changer in the treatment of obesity, cancer, and heart disease,” Gottliebs said.
The FDA is currently reviewing the proposed rules for use in the new medical device, food and beverage, food service and cosmetics industries.
The agency is also considering the potential for the FDA to allow for a limited supply of bioenergy-derived biofuel products.
Biofuels are not considered to be biofuELS, but are instead a form of petroleum-based biofuel that is produced by pumping hydrocarbons from oil or natural gas into the ground to break down organic matter.